CCAAT enhancer-binding protein (C͞EBP)␤, C͞EBP␣, and peroxisome proliferator activated receptor (PPAR)␥ act in a cascade where C͞EBP␤ activates expression of C͞EBP␣ and PPAR␥, which then function as pleiotropic activators of genes that produce the adipocyte phenotype. When growth-arrested 3T3-L1 preadipocytes are induced to differentiate, C͞EBP␤ is rapidly expressed but still lacks DNA-binding activity. After a long (14-hour) lag, glycogen synthase kinase 3␤ enters the nucleus, which correlates with hyperphosphorylation of C͞EBP␤ and acquisition of DNA-binding activity. Concurrently, 3T3-L1 preadipocytes synchronously enter S phase and undergo mitotic clonal expansion, a prerequisite for terminal differentiation. Ex vivo and in vitro experiments with C͞EBP␤ show that phosphorylation of Thr-188 by mitogen-activating protein kinase ''primes'' C͞EBP␤ for subsequent phosphorylation on Ser-184 and Thr-179 by glycogen synthase kinase 3␤, acquisition of DNA-binding function, and transactivation of the C͞EBP␣ and PPAR␥ genes. The delayed transactivation of the C͞EBP␣ and PPAR␥ genes by C͞EBP␤ appears necessary to allow mitotic clonal expansion, which would otherwise be prevented, because C͞EBP␣ and PPAR␥ are antimitotic.
C
CAAT enhancer-binding protein ␤ (C͞EBP␤) is expressed early in the adipocyte differentiation program, first initiating mitotic clonal expansion (MCE) (1, 2) and later activating expression of C͞EBP␣ and peroxisome proliferator-activated receptor ␥ (PPAR␥) (3) (4) (5) (6) , pleiotropic activators of adipocyte genes (3, 4, 7, 8) . Both MCE and expression of C͞EBP␣ and PPAR␥ are required for differentiation (1, 2, 9) . When treated with differentiation inducers, growth-arrested 3T3-L1 preadipocytes synchronously reenter the cell cycle, undergo approximately two rounds of mitosis, then exit the cell cycle and enter the terminal stages of differentiation. Transcriptional activation of the C͞EBP␣ and PPAR␥ genes is induced by the interaction of C͞EBP␤ with C͞EBP regulatory elements in these gene promoters (3) (4) (5) (6) .
Although expression of C͞EBP␤ occurs within 2 h of induction of differentiation, acquisition of DNA-binding activity and thus transcription of the C͞EBP␣ and PPAR␥ genes are delayed (10) . Acquisition of DNA-binding activity begins after a long lag (Ϸ14 h), concurrent with the entry of S phase at the onset of MCE and transcription of the C͞EBP␣ and PPAR␥ genes (ref. 10 and Fig. 1 ). This lag appears necessary, because C͞EBP␣ and PPAR␥ are antimitotic (11) (12) (13) (14) (15) , and their premature expression would otherwise prevent the MCE required for differentiation. To elucidate the mechanism by which C͞EBP␤ acquires DNAbinding activity, we considered the possibility that covalent modification of C͞EBP␤ occurs during this time window.
Several lines of evidence indicated that C͞EBP␤ can be phosphorylated in vitro by a variety of kinases, including PKA (16) , PKC (16) , mitogen-activated protein kinase (MAPK) (17) , and Ca 2ϩ -calmodulin-dependent kinase II (18) . However, functional effects were not observed. We found (10) that treatment of nuclear extracts from 3T3-L1 preadipocytes with alkaline phosphatase disrupted the DNA-binding activity of C͞EBP␤. Thr-188 in C͞EBP␤ was implicated as a phosphorylation site of MAPK in the oncogenic ras signaling pathway (17, 19) and was also found to play roles in keratinocyte survival and skin tumorigenesis (19) and in C͞EBP␤-dependent gene expression in response to IFN-␥ (20) . Phosphorylation of C͞EBP␤ on Ser-105 in rat C͞EBP␤ (Thr-217 in mouse C͞EBP␤) by ribosomal S kinase appears to be required for hepatocyte proliferation during liver regeneration and for the proliferative response of hepatocytes to TGF␣ (21) .
The present paper shows, both ex vivo and in vitro, that C͞EBP␤ is sequentially phosphorylated by MAPK (on Thr-188) and by glycogen synthase kinase 3␤ (GSK3␤) (on Ser-184 and Thr-179) early in the adipocyte differentiation program. Moreover, phosphorylation by MAPK and GSK3␤ in vitro leads to the acquisition of DNA-binding function.
Materials and Methods
Cell Culture, Induction of Differentiation, and Transfection of 3T3-L1 Preadipocytes. Differentiation of postconfluent 3T3-L1 preadipocytes (designated day 0) was as described (22) . The MAPK (U0126, Calbiochem) and GSK3␤ (SB216763, Calbiochem) inhibitors (20 M) were added 1 h before and at the time of induction of differentiation. U0126 was added again 24 h later. Cell number was determined on day 4 and Oil-red-O staining (2) on day 8. Transfections were performed with proliferating preconfluent (at 40-50% confluent cell density) 3T3-L1 preadipocytes by the calcium phosphate coprecipitation method (23) .
EMSA and Chromatin Immunoprecipitation (ChIP) Analysis. Nuclei were isolated and nuclear extracts prepared by using 1ϫ NUN buffer (24) containing 0.3 M NaCl, 1 M urea, 1% Nonidet P-40, 25 mM Hepes (pH 7.9), and 1 mM DTT. EMSA was performed essentially as described (10) . For supershift experiments, 1 l of antiserum (Ϸ5 g of IgG protein) was added to the reaction mixture before addition of the labeled probe. The labeled probe included a double-stranded oligonucleotide corresponding to the sequence of the C͞EBP regulatory element in the C͞EBP␣ gene promoter (4), G 191 CGTTGCGCCACGATCTCTC 172 . ChIP analysis was performed essentially as described (25) . 3T3-L1 preadipocytes were induced to differentiate with or without MAPK (U0126) and GSK3␤ (SB216763) inhibitors; 24 h later, ChIP analysis was performed with primers flanking C͞EBP-binding site in the 422͞aP2 promoter: (i) CCTCCACA-ATGAGGCAAATC and (ii) CTGAAGTCCAGATAGCTC. PCR products were analyzed with 2% agarose.
Immunoblotting. At the times indicated, cell lysates were prepared as described (10) , subjected to SDS͞PAGE, and immunoblotted with the appropriate antibodies. C͞EBP␤, C͞EBP␣, and 422͞ aP2 antibodies were prepared in this laboratory, and the antibody against PPAR␥ was from Mitchell Lazar (University of Pennsylvania, Philadelphia). Antibody against p-Thr-188-C͞ EBP␤ was from Cell Signaling Technology (Beverley, MA). Antibodies against MAPK and phospho-MAPK (Thr-202͞Tyr-204) were from Upstate Biotechnology (Lake Placid, NY) and GSK3␤ antibody from Santa Cruz Biotechnology.
2D Isoelectric Focusing͞SDS͞PAGE. Growth-arrested 3T3-L1 preadipocytes were induced to differentiate as above and nuclei prepared (10) at 4, 16, and 24 h and lysed in buffer containing 8 M urea, 4% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), and 40 mM Tris base. After mixing with rehydration buffer containing 8 M urea, 2% CHAPS, and 2% immobilized pH gradient buffer (pH 3-10), the sample was soaked in IPG strips (pH 3-10), isoelectrofocused by using an IPGphor isoelectric focusing system (Amersham Pharmacia Biotech). Proteins were then further resolved by 5-12% SDS͞ PAGE and C͞EBP␤ detected by immunoblotting. Alkaline phosphatase treatment was performed as described (4) .
Purification, In-Gel Digestion, and Nano-Liquid Chromatography (LC)-Tandem MS (MS͞MS) Analysis of Endogenous C͞EBP␤. A C͞EBP␤ immunoaffinity column was prepared by coupling the purified C-terminal C͞EBP␤ antibody (against CTLRNLFKQLPEPL-LASAGH-OH) to a protein A column using an ImmunePure rProtein A IgG Plus Orientation Kit (Pierce Biotechnology). One hundred 15-cm dishes of 3T3-L1 preadipocytes were induced to differentiate, after which nuclear extracts were prepared 4 and 24 h later by the NUN method (above). C͞EBP␤ protein was purified by using the immunoaffinity column according to the manufacturer's instructions and then subjected to SDS͞PAGE. The band containing C͞EBP␤ (38 kDa) was excised from the gel, digested with trypsin, and analyzed by automated nanoLC-MS͞MS, as described (26 (27) , and incorporation of [ 32 P] into the phosphopeptide was determined. Identical reactions, but with unlabeled ATP, were processed as above. After elution, the peptides were dried down and redissolved in 50 l of acetonitrile and 5% formic acid 1:1 (vol͞vol). Approximately 1 l of the redissolved peptide was analyzed by nanoelectrospray ionization MS. All spectra were obtained in positive ion mode. A potential of 0.7-1.0 kV was applied to the nanospray needle obtained from Proxeon Biosystems (Odense, Denmark).
In Vitro Phosphorylation and Analysis of Full-Length C͞EBP␤. The AAA mutant (Thr-179, Ser-184, and Thr-1883Ala) was constructed by using the QuickChange site-directed mutagenesis kit (Invitrogen). The WT or AAA mutant C͞EBP␤(LAP) (LAP, liver activator protein) was cloned into pGEX-4T (Amersham Pharmacia Biotech), transformed into Escherichia coli [strain BL21(DE3)pLysS; Novagen] and GST-C͞EBP␤ prepared. Two micrograms of WT or AAA mutant C͞EBP␤ was incubated with activated MAPK and͞or GSK3␤ in 100 mM Tris⅐HCl (pH 7.5)͞10 mM MgCl 2 ͞1 mM EGTA͞5 mM DTT͞20 Ci [␥ 32 P] ATP at 30°C for 30 min.
32 P-C͞EBP␤ was detected by autoradiography after SDS͞PAGE. To assess DNA-binding activity (EMSA), an identical reaction mixture with unlabeled ATP was used. To identify amino acids phosphorylated by MAPK and͞or GSK3␤, C͞EBP␤ was purified by SDS͞PAGE and the C͞EBP␤ band cut out and subjected to in-gel digestion and MS analysis.
Results

C͞EBP␤ Undergoes Phosphorylation Correlated with Acquisition of
DNA-Binding Activity During Differentiation. Experiments were conducted to verify and extend our previous studies (10) , suggesting that C͞EBP␤ undergoes changes in phosphorylation state early in the adipocyte differentiation program. Nuclear extracts prepared from preadipocytes at 4, 16, and 24 h after induction of differentiation were subjected to isoelectric focusing͞SDS͞ PAGE (2D gel electrophoresis) and then immunoblotted with anti-C͞EBP␤ antibody. Four hours after induction, C͞EBP␤͞ LAP ( Fig. 1 A) and C͞EBP␤͞LIP (not shown) exhibited high isoelectric points (pI Ϸ9). By 16 h after induction, however, a large fraction (Ϸ50%) of C͞EBP␤͞LAP converted to forms with more acidic pIs and by 24 h, virtually all C͞EBP␤͞LAP shifted to the lower pI forms. These changes were correlated with the acquisition of DNA-binding activity as measured by EMSA with an oligonucleotide probe corresponding to the C͞EBP regulatory element in the C͞EBP␣ gene ( Fig. 1B and ref. 10 ). Four hours after induction, C͞EBP␤ possessed little DNA-binding activity; however, by 16-24 h, DNA-binding activity was acquired (Fig. 1B) . Previously, we showed that acquisition of DNA binding activity begins Ϸ14 h after induction as the preadipocytes synchronously traverse the G 1 -S checkpoint (10) .
To verify that the shifts to more acidic pIs at 16 and 24 h were due to phosphorylation of C͞EBP␤, nuclear extracts were treated with alkaline phosphatase before 2D gel electrophoresis. Phosphatase treatment caused reversal to forms with less acidic pIs approaching those at the 4-h time point (Fig. 1 A) . The shifts at 16 and 24 h to forms with multiple pIs suggested multiple phosphorylation sites. That phosphorylation of C͞EBP␤ is responsible for the acquisition of DNA-binding activity was verified by EMSA. As illustrated in Fig. 1B and previously inferred (10) phosphatase treatment of nuclear extract prepared 24 h after induction of differentiation disrupted DNA-binding activity. Thus, acquisition of DNA-binding activity appears to depend upon phosphorylation of C͞EBP␤ at Ϸ14 h, as the cells enter S phase, and reaches a maximum at 24 h (10). Changes in phosphorylation state and DNA-binding activity of C͞EBP␤ during differentiation. Two-day postconfluent 3T3-L1 preadipocytes were induced to differentiate nuclear extracts prepared at 4, 16, and 24 h after induction (treated or not with alkaline phosphatase) and then subjected to (A) 2D gel analysis and immunoblotting with anti-C-terminal C͞EBP␤ antibody and (B) EMSA to assess DNA-binding activity using a oligonucleotide probe corresponding to the C͞EBP regulatory element in the proximal promoter of the C͞EBP␣ gene.
Phosphorylation of the Thr-188 MAPK Site in C͞EBP␤ During Differentiation. To determine whether phosphorylation of C͞EBP␤ at this Thr-188 correlates with acquisition of DNA-binding activity, the kinetics of phosphorylation after induction was monitored by with antiphosphopeptide antibody to the MAPK site at phosphoThr-188. Parallel gels were immunoblotted with antibody to a peptide corresponding to the C terminus of C͞EBP␤ ( Fig. 2A) . Consistent with previous findings (10), C͞EBP␤ was rapidly (Յ4 h) expressed after induction to level that remained constant for at least 24 h. Phosphorylation of Thr-188 in C͞EBP␤ LAP occurred immediately (Յ4 h) after induction (Fig. 2B) .
That MAPK is responsible for the rapid phosphorylation of C͞EBP␤ LAP after induction is supported by the fact that MAPK itself is rapidly phosphorylated (Fig. 2C ) and thereby activated after induction remaining relatively constant for the next 8 h (Fig. 2C) . Despite phosphorylation at Thr-188, however, DNA-binding activity was not acquired at 4 h but was delayed until 14-16 h after induction (10) (Fig. 1B) . Thus, phosphorylation at Thr-188 alone is insufficient to affect DNA-binding activity.
Although phosphorylation of Thr-188 alone is insufficient for acquisition of DNA-binding activity, that this site is required is suggested by the fact that mutation of Thr-188 disrupts transactivation by C͞EBP␤. Thus, mutation of Thr-188 disrupted reporter gene expression driven by C͞EBP␤ (Fig. 2D) . (Fig. 1 A) indicated that C͞EBP␤ is phosphorylated at multiple sites during MCE, investigations were conducted to identify the phosphorylation sites. 3T3-L1 preadipocytes were induced to differentiate and nuclear extracts prepared at 4 and 24 h after induction. C͞EBP␤ was purified from the nuclear extracts by using an immunoaffinity matrix, elution being accomplished with low pH buffer. Purified C͞EBP␤ was separated by SDS͞PAGE, and the band corresponding to C͞EBP␤(LAP) was excised and digested with trypsin. Automated nanoLC-MS͞MS analysis of the digested gel band identified eight peptides that correspond to a total sequence coverage of 40%. One triply charged peptide (m͞z 1,094.48) showed a characteristic loss of phosphoric acid (loss of 98 Da) and was identified as a singly phosphorylated peptide (data not shown). The MS͞MS data obtained from automated nanoLC-MS͞MS analysis did not provide sufficient sequence information to localize the exact phosphorylation site in C͞EBP␤. However, manual selection of the identified phosphopeptide (m͞z 1,094.48) during an LC-MS͞MS run, combined with manual peak parking, showed that this peak corresponded to a mixture of two singly phosphorylated peptides that were phosphorylated on Thr-179 (Fig. 3A) or Ser-184 (Fig. 3B) . The presence of dehydroaminobutyric acid and dehydroalanine, respectively, was the result of a gas phase ␤-elimination reaction. Both of these are phosphorylation sites not previously identified in C͞EBP␤. These residues (Thr-179 and Ser-184) are located in a region rich in Pro and Gly residues just N-terminal to the Thr-188 MAPK phosphorylation site and thus have the characteristic of sites phosphorylated by GSK3␤ (Fig. 3C) .
Phosphorylation of WT and Mutant Peptides by MAPK and GSK3␤. The evidence presented above suggested that phosphorylation of Thr-188 by MAPK may be the first event in a phosphorylation cascade. To test the possibility that phosphorylation of Thr-188 
Fig. 3. Identification of phosphorylation sites in C͞EBP␤ during differentiation. (A and B)
Nuclear extracts were prepared before and 24 h after induction of differentiation. C͞EBP␤ was isolated and separated by SDS͞ PAGE. The band containing C͞EBP␤ (38 kDa) was excised from the gel, digested by trypsin, and analyzed by automated nanoLC-MS͞MS as described (26) . Ions labeled with an asterisk were generated from the peptide in which the phosphoserine and phosphothreonine were converted into dehydroalanine and dehydroaminobutyric acid by ␤-elimination, respectively. (A) Partial MS͞MS spectrum of one of the species in which the phosphorylation site was localized to Thr-179. (B) Partial MS͞MS spectrum of the second species where the phosphorylation site was localized to Ser-184. (C) Amino acid sequence of the tryptic peptide identifying the phosphorylation sites in Fig. 2B (Thr-188) and in A (Thr-179) and B (Ser-184) above.
by MAPK is required for subsequent hyperphosphorylation at Thr-179 and Ser-184, three peptides (WT, a Thr-1883Ala mutant peptide, and a P-Thr-188 phosphopeptide; Fig. 4A ) were synthesized and tested in vitro as substrates for MAPK and GSK3␤ by using [␥-32 P] ATP as phosphoryl donor. Mutation of Thr-188 to Ala almost completely abolished phosphorylation by MAPK (Fig. 4B) . This is consistent with the fact that (i) the same mutation (Thr-1883 Ala) disrupts transactivation of the C͞EBP␣ promoter by C͞EBP␤ (Fig. 2D ) and (ii) the rapid phosphorylation of C͞EBP␤ (4 h after induction; Fig. 2B ) closely follows phosphorylation͞activation of MAPK (Fig. 2C) .
The two phosphorylation sites in C͞EBP␤ identified above, i.e., Thr-179 and Ser-184, are potential GSK3␤ phosphorylation sites. GSK3␤ possesses unique substrate specificity, in that its substrates must initially undergo phosphorylation by another protein kinase at a serine or threonine located approximately four residues C-terminal to the GSK3␤ phosphorylation site (28) . The two phosphorylation sites, i.e., Thr-179 and Ser-184 and the MAPK site at Thr-188 in C͞EBP␤, fit this consensus requirement (Fig. 3C) . To determine whether Thr-179 and Ser-184 can be phosphorylated by GSK3␤ and whether phosphorylation of Thr-188 (Fig. 2B) by MAPK is required, the three peptides (Fig. 4A) were tested in vitro as substrates for GSK3␤ by using [␥-32 P] ATP as phosphoryl donor. Consistent with the predicted phosphorylation pattern for GSK3␤ substrates, phospho-Thr-188 peptide was an excellent substrate, whereas the WT and Thr-1883Ala mutant peptides were poor substrates (Fig. 4C) . Although far less active than the phospho-Thr-188 peptide, the WT peptide was 10 times more active as a substrate than the Thr-1883Ala mutant peptide. To identify the amino acid(s) phosphorylated by GSK3␤, the same reaction was performed with unlabeled ATP, after which the peptides were purified and analyzed by MS. MS analysis of the peptides after phosphorylation by GSK-3␤ showed that almost all of the phospho-Thr-188 peptide became doubly phosphorylated (Fig. 4D) . However, only a small fraction of the WT peptide became doubly phosphorylated, most remaining in the unphosphorylated form (Fig. 4D) . No phosphorylation of the mutant Thr-1883Ala peptide was detected (Fig. 4D) . Sequence analysis of the product of phospho-Thr-188 peptide showed that the product contained two populations, one phosphorylated on Thr-188 and Thr-179 (Fig. 8A , which is published as supporting information on the PNAS web site) and another phosphorylated on Thr-188 and Ser-184 (Fig. 8B) . Together, these results show that phosphorylation of Thr-188 (by MAPK) serves to prime phosphorylation at Thr-179 and Ser-184 by GSK3␤.
Translocation of GSK3␤ from Cytoplasm to Nucleus Concomitant with
Hyperphosphorylation and Acquisition of DNA-Binding Activity. Previous studies showed that C͞EBP␤ translocates to the nucleus immediately after induction of differentiation (10) . Because there is a 12-to 14-h lag before C͞EBP␤ acquires DNA-binding activity (ref. 10 and Fig. 1B ) and undergoes hyperphosphorylation at Thr-179 or Ser-184, it was of interest to determine whether the putative kinase, GSK3␤, is present in the nucleus at this point in the program. Intracellular localization experiments (Fig. 9 , which is published as supporting information on the PNAS web site) revealed that before 12 h after induction, GSK3␤ does not exhibit nuclear localization. However, between 12 and 16 h, Ϸ25% of GSK3␤ enters the nucleus, after which the level remains constant. Thus, the kinetics of translocation of GSK3␤ into the nucleus is consistent with its suspected role in the hyperphosphorylation of C͞EBP␤ (Fig. 1A) and the acquisition of DNA-binding activity (Fig. 1B and ref. 10) .
In Vitro Phosphorylation of Full-Length Recombinant C͞EBP␤ on Thr-188 and Ser-184͞Thr-179 Gives Rise to DNA-Binding Activity.
Full-length C͞EBP␤(LAP) was overexpressed in E. coli as a GST fusion protein, purified, and incubated either without or with MAPK, GSK3␤, or both in the presence of [␥-32 P] ATP. C͞EBP␤ was phosphorylated by MAPK alone but not by GSK3␤ alone (Fig. 5A ). Incubation with MAPK, then GSK3␤, however, increased the extent of phosphorylation by Ϸ2-fold relative to that by MAPK alone (Fig. 5A) . This is consistent with in vitro phosphorylation of synthetic peptide substrates corresponding to the phosphorylated region in C͞EBP␤ (Fig. 4) .
To identify the amino acids in full-length C͞EBP␤(LAP) that were phosphorylated in vitro, experiments similar to those above were performed. After separation by SDS͞PAGE, the band corresponding to C͞EBP␤(LAP) was excised, digested with trypsin, and subjected to MS analysis. Only one triply charged singly phosphorylated species was found with MAPK alone (Fig.  5C) ; this phosphorylation site was identified as Thr-188 (Fig. 10 , which is published as supporting information on the PNAS web site). Analysis of the peptide phosphorylated by MAPK and GSK3␤ together revealed a doubly phosphorylated species (Fig.  5C) . MS͞MS showed two different populations of doubly phosphorylated peptides, one phosphorylated on Thr-188 and Ser-184 (Fig. 11 , which is published as supporting information on the PNAS web site) and another phosphorylated on Thr-188 and Ser-179 (results similar to those shown in Fig. 11 ; not shown). No phosphorylation product was detected with GSK3␤ alone (Fig.  5C ). These results show that full-length C͞EBP␤ is phosphorylated on Thr-188 by MAPK, and that this phosphorylation serves as the priming site for phosphorylation of Ser-184͞Thr-179 by GSK3␤. An identical experiment was performed, after which DNAbinding activity was assessed by gel-shift analysis with a labeled oligonucleotide corresponding to the C͞EBP-binding site in the C͞EBP␣ gene promoter. DNA-binding activity was acquired only after C͞EBP␤(LAP) was phosphorylated by both MAPK and GSK3␤ (Fig. 5B ). Unphosphorylated C͞EBP␤(LAP) or C͞EBP␤(LAP) phosphorylated by MAPK did not exhibit significant DNA-binding activity. Consistent with these results, mutation of the three phosphorylation sites (Thr-1883Ala, Ser-1843Ala and Thr-1793Ala; AAA mutant) prevented phosphorylation by MAPK and GSK3␤, the acquisition of DNA-binding activity (Fig. 6A) , and transactivation function (Fig. 6B) . Together, these results show that phosphorylation of C͞EBP␤(LAP) on Thr-188 is required for further phosphorylation on Ser-184͞Thr-179 by GSK3␤ and for acquisition of DNA-binding activity.
Effect of MAPK and GSK3␤ Inhibitors on DNA Binding by C͞EBP␤ and
Adipogenesis. To determine whether inhibition of the MAPK or GSK3␤ affects the cellular functions of C͞EBP␤, 3T3-L1 preadipocytes were treated with U0126 (a MEK͞MAPK inhibitor) or SB216763 (a GSK3␤ inhibitor) at the time of induction of differentiation. At various times after induction of differentiation the DNA-binding activity of C͞EBP␤, MCE, expression of differentiation markers and accumulation of cytoplasmic triglyceride were assessed. Both inhibitors blocked MCE (Fig. 12 , which is published as supporting information on the PNAS web site) and drastically curtailed the DNA-binding activity of C͞EBP␤ as assessed by EMSA (Fig. 7A) . Specificity of binding was verified by supershifting with antibody to C͞EBP␤. In addition, ChIP experiments revealed that both the MAPK and GSK3␤ inhibitors disrupted binding of C͞EBP␤ to chromatin associated with the C͞EBP regulatory element in the 422͞aP2 gene promoter (Fig. 7B) . Both inhibitors also blocked adipogenesis, as indicated by the inhibition of expression of adipocyte markers, i.e., C͞EBP␣, PPAR␥, and 422͞aP2 (Fig. 7D) , and the accumulation of cytoplasmic triacylglycerol (Fig. 7C) .
Discussion
C͞EBP␤ is immediately expressed and phosphorylated by MAPK within 2-4 h after induction of differentiation (Fig. 2 A  and B ; see also ref. 10) . At this point, however, C͞EBP␤ lacks DNA-binding activity ( Fig. 1B; see also ref. 10) . After a lag of 12-14 h, C͞EBP␤ undergoes hyperphosphorylation (Fig. 1 A) and acquisition of DNA-binding activity as the preadipocytes pass the G 1 -S checkpoint. The cells then undergo approximately two rounds of mitosis (MCE) and begin to express genes that produce the adipocyte phenotype (10) .
Hyperphosphorylation of C͞EBP␤ was detected by isoelectric focusing shifts to forms of lower-pI, presumably phosphorylated forms (Fig. 1 A) . The shifts between 4 and 16-24 h after induction of differentiation were accompanied by the acquisition of DNA-binding activity (Fig. 1B) . This correlation between hyperphosphorylation and binding activity suggested a causal relationship, because phosphatase treatment caused both loss of anionic character and DNA-binding activity by C͞EBP␤ (Fig. 1) . Thus, it appeared that hyperphosphorylation of C͞EBP␤, which occurs at the G 1 -S checkpoint (10, 29) , is responsible for the gain of DNA-binding function.
Here we provide evidence that C͞EBP␤ is phosphorylated sequentially, first by MAPK and then by GSK3␤, at widely separated time points in the differentiation program. Phosphorylation on Thr-188 by MAPK occurs early in the program, i.e., within the first 4 h after induction (Fig. 2 A) , long before C͞EBP␤ acquires DNA-binding activity. This phosphorylation event is of functional importance, however, because inhibition of MAPK prevents MCE (Fig. 12 ) and the acquisition of DNAbinding activity (Fig. 7 A and B) , as well as terminal differentiation ( Fig. 7 C and D) . Thus, phosphorylation of C͞EBP␤ by MAPK is required but is insufficient for acquisition of DNAbinding activity.
C͞EBP␤ is localized within nuclei throughout the differentiation program beginning at 4 h after induction (10), whereas GSK3␤ is initially localized exclusively in the cytoplasmic compartment. However 12-14 h after induction at the G 1 -S checkpoint, Ϸ25% of the GSK3␤ translocates into the nucleus (29) (Fig. 9) , coincident with the onset of hyperphosphorylation and ''activation'' of C͞EBP␤ (Fig. 1) . Consistent with the role of GSK3␤ in the hyperphosphorylation of C͞EBP␤ is the fact that the two newly identified phosphorylation sites in C͞EBP␤, i.e., Thr-179 and Ser-184, possess the consensus sequence pattern usually targeted by GSK3 (28) .
In vitro phosphorylation of WT and mutant full-length C͞EBP␤(LAP) and peptides corresponding to the phosphorylated region of C͞EBP␤ by MAPK and GSK3␤ provide definitive evidence that a priming phosphorylation at Thr-188 is required for phosphorylation at Thr-179 and Ser-184 catalyzed by GSK3␤ (Figs. 4, 5, 8, 10, and 11) . Consistent with the predicted phosphorylation pattern for GSK3␤ substrates (28) , phosphorylation of Thr-188 is required for phosphorylation at Thr-179 or Ser-184. MS analysis of the phosphopeptides verified the phosphorylation of phospho-Thr-188 by GSK3␤ at Thr-179 and Ser-184 (Figs. 8 and 11) . Thus, C͞EBP␤ appears to undergo a ''priming'' phosphorylation at Thr-188 catalyzed by MAPK shortly after (Յ2-to 4-h) induction and subsequently (12-16 h) hyperphosphorylation (presumably by GSK3␤) at Thr-179 and Ser-184 (Fig. 2, 4 , and 5). Phosphorylation of Thr-179 and Ser-184 correlates closely with the kinetics of translocation of GSK3␤ from the cytoplasm to the nucleus (29) and the acquisition of DNA-binding activity by C͞EBP␤ (Figs. 1 and 5 ).
Although the mechanism by which hyperphosphorylation ''activates'' DNA-binding activity of C͞EBP␤ has not been determined, it is likely to involve a conformational change(s) that exposes the binding domain. Johnson's group proposed a model (30) in which a regulatory domain [regulatory domain 2 (RD2)] of C͞EBP␤ interacts intramolecularly with (and obscures) the DNA-binding domain. Their findings suggested that C͞EBP␤ exists in a tightly folded conformation in which the DNA-binding domain is masked. It is of interest that the amino acids phosphorylated by MAPK and GSK3␤, i.e., Thr-179, Ser-184, and Thr-188, lie within the RD2 regulatory region (residues 162-192) identified by Johnson's group. Thus, our findings are consistent with and lend credence to the suggestion that phosphorylation, in this case hyperphosphorylation of C͞EBP␤, may be responsible for the unmasking of the DNAbinding domain of C͞EBP␤.
